
|Podcasts|July 13, 2019
Tapping Into Great Progress Made in GI Cancers in Tampa
Author(s)Onclive Team
We traveled to Tampa, Florida, for a State of the Science Summit™ on Gastrointestinal Malignancies, which featured insights from the faculty from Moffitt Cancer Center and Mayo Clinic.
Advertisement
We recently traveled to Tampa, Florida, for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, faculty from Moffitt Cancer Center and Mayo Clinic reviewed the latest data in gastrointestinal oncology, covering all aspects of current care, from patient selection to the optimal timing of targeted therapy, immunotherapy, and chemotherapy, in neuroendocrine tumors, hepatocellular carcinoma, pancreatic cancer, gastric and gastroesophageal cancer, and colorectal cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5




































